- Home
- OGE vs BMRN Comparison
OGE vs BMRN Comparison
Compare OGE & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OGE | BMRN |
|---|---|---|
| Founded | 1902 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0B | 10.5B |
| IPO Year | 2009 | 1999 |
Fundamental Metrics
Financial Performance| Metric | OGE | BMRN |
|---|---|---|
| Price | $47.57 | $54.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 18 |
| Target Price | $48.11 | ★ $88.22 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 04-29-2026 | 04-24-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | ★ 5.94 | N/A |
| EPS | ★ 2.32 | 1.80 |
| Revenue | ★ $3,260,100,000.00 | $1,313,646,000.00 |
| Revenue This Year | $3.74 | $15.02 |
| Revenue Next Year | $1.42 | $12.23 |
| P/E Ratio | ★ $19.81 | $29.96 |
| Revenue Growth | 9.21 | ★ 17.62 |
| 52 Week Low | $41.70 | $50.76 |
| 52 Week High | $50.13 | $66.28 |
Technical Indicators
Market Signals| Indicator | OGE | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 47.67 | 41.40 |
| Support Level | $46.36 | $53.45 |
| Resistance Level | $49.16 | $56.21 |
| Average True Range (ATR) | 0.89 | 1.28 |
| MACD | -0.29 | -0.01 |
| Stochastic Oscillator | 40.98 | 19.32 |
Price Performance
Historical ComparisonAbout OGE OGE Energy Corp
OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.